Erythema multiforme

L12_ERYTHEMAMULTIF

erythema multiforme: Erythema multiforme (EM) refers to a group ofhypersensitivity disorders characterized by symmetric red, patchy lesions, primarily on the arms and legs. The cause is unknown, but EM frequently occurs in association with herpes simplex virus , suggesting an immunologic process initiated by the virus. In half of the cases, the triggering agents appear to be medications, including anticonvulsants, sulfonamides, nonsteroidal anti-inflammatory drugs, and other antibiotics. In addition, some cases appear to be associated with infectious organisms such as Mycoplasma pneumoniae and many viral agents. Erythema multiforme is the mildest of three skin disorders that are often discussed in relation to each other. It is generally the mildest of the three. More severe is Stevens-Johnson syndrome . The most severe of the three is toxic epidermal necrolysis (TEN).

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 L51
Hospital discharge: ICD-9 6951A|6951B|6951C
Hospital discharge: ICD-8 69510
Cause of death: ICD-10 L51
Cause of death: ICD-9 6951A|6951B|6951C
Cause of death: ICD-8 69510

2 out of 7 registries used, show all original rules.

631

diagram downward connector

Check minimum number of events None

631

diagram downward connector

Include endpoints None

631

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

612

diagram downward connector
L12_ERYTHEMAMULTIF

Control definitions

Control exclude L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L50-L54
Name in latin Erythema multiforme

Summary Statistics

Key figures

All Female Male
Number of individuals 612 374 238
Unadjusted prevalence (%) 0.16 0.18 0.14
Mean age at first event (years) 48.05 46.12 51.07

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.09 [0.94, 4.63] 7.0e-2 71
15 years 0.01 1.12 [0.53, 2.34] 7.7e-1 27
5 years 0.00 3.38 [1.71, 6.67] 4.4e-4 22
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_ERYTHEMAMULTIF – Erythema multiforme
GWS hits:

Survival analyses between endpoints

Plot

before Erythema multiforme
after Erythema multiforme

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Erythema multiforme

Endpoint not on priority list, no data to show.